The Role of An Experimental Model of Atherosclerosis: apoE-knockout Mice in Developing New Drugs against Atherogenesis

Publisher： Bentham Science Publishers

E-ISSN： 1873-4316|13|13|2435-2439

ISSN： 1389-2010

Source： Current Pharmaceutical Biotechnology, Vol.13, Iss.13, 2012-10, pp. : 2435-2439

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

In vivo examination of 111In-bis-5HT-DTPA to target myeloperoxidase in atherosclerotic ApoE knockout mice

By Wu Ming-Che   Ho Hsin-I   Lee Te-Wei   Wu Hua-Lin   Lo Jem-Mau  

Journal of Drug Targeting, Vol. 20, Iss. 7, 2012-08 ,pp. : 605-614

Informa Healthcare

Access to resources Recommend Favorite

Naoxintong Protects against Atherosclerosis through Lipid-lowering and Inhibiting Maturation of Dendritic Cells in LDL Receptor Knockout Mice fed a High-fat Diet

By  

Current Pharmaceutical Design, Vol. 19, Iss. 33, 2013-10 ,pp. : 5891-5896

Bentham Science Publishers

Access to resources Recommend Favorite

Ursane Triterpenoids Inhibit Atherosclerosis and Xanthoma in LDL Receptor Knockout Mice

By Zhang Qin   Chang Zai   Wang Qiang  

Cardiovascular Drugs and Therapy, Vol. 20, Iss. 5, 2006-10 ,pp. : 349-357

Springer Publishing Company

Access to resources Recommend Favorite

Genistein inhibits the development of atherosclerosis via inhibiting NF-κB and VCAM-1 expression in LDLR knockout mice

By Wang Bin   Li Shengnan   Wang Juejin   Zhang Rongjian   Xu Youhua   Zhou Hong  

Canadian Journal of Physiology and Pharmacology, Vol. 86, Iss. 11, 2008-11 ,pp. : 777-784

NRC Research Press

Access to resources Recommend Favorite

Dissecting the role of the serotonin system in neuropsychiatric disorders using knockout mice

By Gingrich Jay A.   Hen René  

Psychopharmacology, Vol. 155, Iss. 1, 2001-04 ,pp. : 1-10

Springer Publishing Company

Access to resources Recommend Favorite